KPTI position history
The shares of Karyopharm Therapeutics (KPTI) that DAVIDSON KEMPNER CAPITAL MANAGEMENT LP reported in each quarter’s 13F.
Shares held by quarter
New Add Reduce Exit
- 2025 Q4: 310,020 shares, $2.3M, 0.04% of portfolio, New
- 2026 Q1: 300,000 shares, $1.7M, 0.02% of portfolio, Reduce −3.2%
- 2026 Q2: 300,000 shares, $2.9M, 0.03% of portfolio
| Holdings date | Value | % of holdings | Shares | Filing date | All 13F holders |
|---|